US Stock MarketDetailed Quotes
EVOK Evoke Pharma
- 4.5916
- +0.0316+0.69%
Trading Nov 21 13:42 ET
6.82MMarket Cap-453P/E (TTM)
4.5916High4.5144Low11.07KVolume4.5800Open4.5600Pre Close50.44KTurnover0.88%Turnover RatioLossP/E (Static)1.49MShares17.400052wk High1.56P/B5.78MFloat Cap3.540052wk Low--Dividend TTM1.26MShs Float2052.0000Historical High--Div YieldTTM1.69%Amplitude3.5400Historical Low4.5570Avg Price1Lot Size
Evoke Pharma Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | 90.10%11.34M | 30.99%9.18M | 18.14%9.7M | -51.85%4.74M | -51.85%4.74M | -51.70%5.96M | -47.91%7.01M | 6.64%8.21M | 7.64%9.84M | 7.64%9.84M |
| -Cash and cash equivalents | 90.10%11.34M | 30.99%9.18M | 18.14%9.7M | -51.85%4.74M | -51.85%4.74M | -51.70%5.96M | -47.91%7.01M | 6.64%8.21M | 7.64%9.84M | 7.64%9.84M |
| Receivables | 63.91%2.02M | 95.64%2M | 111.25%1.45M | 7.72%673.07K | 7.72%673.07K | 82.81%1.23M | 180.00%1.02M | 64.07%687.3K | 111.67%624.83K | 111.67%624.83K |
| -Accounts receivable | 63.91%2.02M | 95.64%2M | 111.25%1.45M | 7.72%673.07K | 7.72%673.07K | 82.81%1.23M | 180.00%1.02M | 64.07%687.3K | 111.67%624.83K | 111.67%624.83K |
| Inventory | -2.28%493.41K | 6.04%544.77K | 61.37%588.78K | 66.51%481.84K | 66.51%481.84K | 129.19%504.93K | 91.44%513.71K | 30.88%364.87K | 55.97%289.38K | 55.97%289.38K |
| Prepaid assets | 287.54%146.7K | 3.12%382.94K | 4.89%704.22K | -7.13%885.04K | -7.13%885.04K | --37.86K | 20.60%371.35K | 9.02%671.39K | 3.16%952.95K | 3.16%952.95K |
| Other current assets | -62.87%36.42K | 139.59%27.68K | -45.36%6.31K | 311.50%47.53K | 311.50%47.53K | 749.23%98.09K | 0.00%11.55K | 0.00%11.55K | 0.00%11.55K | 0.00%11.55K |
| Total current assets | 79.07%14.04M | 35.95%12.14M | 25.19%12.45M | -41.76%6.83M | -41.76%6.83M | -40.86%7.84M | -38.03%8.93M | 10.21%9.95M | 11.00%11.72M | 11.00%11.72M |
| Non current assets | ||||||||||
| Net PPE | ---- | ---- | ---- | --0 | --0 | -91.30%13.37K | --52.84K | --91.4K | 938.57%129.07K | 938.57%129.07K |
| -Gross PPE | ---- | ---- | ---- | --0 | --0 | -91.30%13.37K | --52.84K | --91.4K | 938.57%129.07K | 938.57%129.07K |
| Non current deferred assets | --115.49K | --0 | --0 | --241.64K | --241.64K | ---- | ---- | ---- | --0 | --0 |
| Total non current assets | 763.78%115.49K | --0 | --0 | 87.21%241.64K | 87.21%241.64K | -91.30%13.37K | --52.84K | --91.4K | 938.57%129.07K | 938.57%129.07K |
| Total assets | 80.23%14.15M | 35.15%12.14M | 24.05%12.45M | -40.36%7.07M | -40.36%7.07M | -41.44%7.85M | -37.66%8.98M | 11.22%10.04M | 12.09%11.85M | 12.09%11.85M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | --2.19M | --2.18M | --1.95M | 83.21%1.71M | 83.21%1.71M | ---- | ---- | ---- | --934.31K | --934.31K |
| -accounts payable | --2.19M | --2.18M | --1.95M | 83.21%1.71M | 83.21%1.71M | ---- | ---- | ---- | --934.31K | --934.31K |
| Current accrued expenses | --1.99M | --1.86M | --1.74M | --1.61M | --1.61M | ---- | ---- | ---- | --0 | --0 |
| Current debt and capital lease obligation | 37,297.16%5M | 9,362.17%5M | 5,370.64%5M | 3,773.75%5M | 3,773.75%5M | -90.47%13.37K | --52.84K | --91.4K | 938.57%129.07K | 938.57%129.07K |
| -Current debt | --5M | --5M | --5M | --5M | --5M | ---- | ---- | ---- | ---- | ---- |
| -Current capital lease obligation | ---- | ---- | ---- | --0 | --0 | -90.47%13.37K | --52.84K | --91.4K | 938.57%129.07K | 938.57%129.07K |
| Current liabilities | 335.91%9.77M | 355.11%9.47M | 433.91%8.96M | 483.13%9.65M | 483.13%9.65M | 19.30%2.24M | 53.80%2.08M | 23.65%1.68M | 17.70%1.65M | 17.70%1.65M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | ---- | ---- | ---- | ---- | ---- | -0.27%5M | 0.00%5M | 0.00%5M | 0.00%5M | 0.00%5M |
| -Long term debt | ---- | ---- | ---- | ---- | ---- | 0.00%5M | 0.00%5M | 0.00%5M | 0.00%5M | 0.00%5M |
| Non current accrued expenses | ---- | ---- | ---- | --0 | --0 | 50.70%1.49M | 58.12%1.36M | 67.97%1.24M | 81.66%1.11M | 81.66%1.11M |
| Total non current liabilities | --0 | --0 | --0 | --0 | --0 | 8.11%6.49M | 8.53%6.36M | 8.72%6.24M | 8.91%6.11M | 8.91%6.11M |
| Total liabilities | 11.91%9.77M | 12.20%9.47M | 13.19%8.96M | 24.22%9.65M | 24.22%9.65M | 10.78%8.73M | 17.02%8.44M | 11.57%7.91M | 10.67%7.77M | 10.67%7.77M |
| Shareholders'equity | ||||||||||
| Share capital | -73.35%89 | -78.14%73 | 157.19%859 | 0.00%334 | 0.00%334 | 0.00%334 | 0.00%334 | -89.85%334 | 22.79%334 | 22.79%334 |
| -common stock | -73.35%89 | -78.14%73 | 157.19%859 | 0.00%334 | 0.00%334 | 0.00%334 | 0.00%334 | -89.85%334 | 22.79%334 | 22.79%334 |
| -Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Retained earnings | -5.06%-127.6M | -5.45%-126.29M | -6.05%-125.02M | -6.74%-123.44M | -6.74%-123.44M | -6.68%-121.45M | -7.09%-119.76M | -7.57%-117.89M | -7.66%-115.65M | -7.66%-115.65M |
| Paid-in capital | 9.46%131.99M | 7.19%128.95M | 7.08%128.52M | 0.94%120.86M | 0.94%120.86M | 1.01%120.58M | 1.07%120.3M | 7.61%120.02M | 7.89%119.73M | 7.89%119.73M |
| Total stockholders'equity | 602.09%4.39M | 395.00%2.66M | 64.48%3.5M | -163.15%-2.58M | -163.15%-2.58M | -115.79%-873.78K | -92.51%538.37K | 9.93%2.13M | 14.90%4.08M | 14.90%4.08M |
| Total equity | 602.09%4.39M | 395.00%2.66M | 64.48%3.5M | -163.15%-2.58M | -163.15%-2.58M | -115.79%-873.78K | -92.51%538.37K | 9.93%2.13M | 14.90%4.08M | 14.90%4.08M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data